The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
Condition(s):Acute Respiratory DistressLast Updated:June 18, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Respiratory DistressLast Updated:June 18, 2023Not yet recruiting
Condition(s):Myocardial IschemiaLast Updated:April 28, 2022Not yet recruiting
Condition(s):Coronary Artery DiseaseLast Updated:February 28, 2018Completed
Condition(s):Heart Defects, Congenital; Cardiac Surgical Procedures; Myocardial Reperfusion Injury; AdenosineLast Updated:April 15, 2009Completed
Condition(s):Premature Ventricular Contraction (PVC)Last Updated:September 26, 2023Recruiting
Condition(s):Pathological Processes; CardiomyopathiesLast Updated:April 20, 2017Unknown status
Condition(s):IschemiaLast Updated:May 7, 2019Terminated
Condition(s):Atrial FibrillationLast Updated:November 6, 2017Completed
Condition(s):Sinus Bradycardia; Atrioventricular BlockLast Updated:February 8, 2018Completed
Condition(s):Atrial Fibrillation; Persistent Common Pulmonary VeinLast Updated:April 26, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.